Company intelligence / Profile preview
AIM Persistence Biopharmaceutical
Shenyang, Liaoning, Chinaaimvaccine.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
AIM Persistence Biopharmaceutical is a specialized biotechnology company based in China and a key subsidiary of AIM Vaccine Co., Ltd. The company focuses on the research, development, and large-scale manufacturing of human vaccines, with a primary emphasis on rabies prevention. Its flagship product is a human rabies vaccine (Vero cell) which is widely distributed across the Chinese market. AIM Persistence operates advanced manufacturing facilities that comply with international GMP standards to ensure the supply of high-quality immunization products.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on AIM Persistence Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AIM Persistence Biopharmaceutical.